Considerations for Insulin-Treated Type 2 Diabetes Patients During Hospitalization: A Narrative Review of What We Need to Know in the Age of Second-Generation Basal Insulin Analogs.

Although the rate of overall symptomatic hypoglycemia (primary endpoint) was lower with degludec U200 compared with glargine U300 (216.8 versus 243.9 events per 100 patient-years of experience [PYE]), the difference did not reach statistical significance (RR 0.88 [0.73; 1.06] 95% CI ).

also in 111,027 other papers